Shareholding disclosure

UBS Group AG

Declared position

28.115%

Threshold

Crossed upwards

Timeline

Published

29.10.2024

Transaction

22.10.2024

Voting rights breakdown

Voting rights acquired28.115%

Voting rights sold1.064%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000P812

Beneficial owner

UBS Group AG

Declared address

UBS Group AG, Zürich, CH

Crossing above 20% in voting rights (Section 4.1 and 4.3).

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

UBS Group AG

DocMorris AG29.10.2024ZA01-000000000P812

Disclosure summary

UBS Group AG disclosed a holding in DocMorris AG on the acquisition side, published by SIX Exchange Regulation on 29.10.2024, at 28.115% of voting rights. Notice category: Single shareholder.

Disclosed position

28.115%

Voting rights acquired

Voting rights acquired28.115%

Voting rights sold1.064%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

UBS Group AG disclosed a holding in DocMorris AG, published on 29.10.2024.

Publication date29.10.2024

Transaction date22.10.2024

Issuing companyDocMorris AG

Beneficial ownerUBS Group AG

Declared addressUBS Group AG, Zürich, CH

CategorySingle shareholder

Voting rights acquired28.115%

Voting rights sold1.064%

Below threshold0%

ExchangeXSWX

Notification IDZA01-000000000P812

Commercial register

CHE-395.345.924

Registered

Zefix record

Conditions

Crossing above 20% in voting rights (Section 4.1 and 4.3).

Source: SIX Exchange Regulation · Publication date: 29.10.2024

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open